Causeway Capital Management LLC Eli Lilly & CO Transaction History

Causeway Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $9,016 - $10,612	-81 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $117 Million - $131 Million	-1,107,491 Reduced 99.99%	81 $9,000
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $140 Million - $175 Million	-1,629,986 Reduced 59.54%	1,107,572 $119 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $73.3 Million - $84.1 Million	-968,402 Reduced 26.13%	2,737,558 $234 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $61.3 Million - $72.4 Million	825,928 Added 28.68%	3,705,960 $287 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $10.5 Million - $11.2 Million	-127,928 Reduced 4.25%	2,880,032 $243 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $232 Million - $257 Million	3,007,960	3,007,960 $257 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Causeway Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Causeway Capital Management LLC with notifications on news.